PLRX — PLIANT THERAPEUTICS INC

Ownership history in Stonepine Capital Management, LLC  ·  2 quarters on record

This page tracks every 13F SEC filing in which Stonepine Capital Management, LLC reported a position in PLIANT THERAPEUTICS INC (PLRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.35% (2025 Q3)
Avg. % of fund
0.28%
First filed
2025 Q3
Last filed
2025 Q4
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 230,050 -59,187 -20.5% 0.20% $281K $1.22
2025 Q3 INITIATED 289,237 — — 0.35% $428.1M $1.48
% of Fund (quarterly)    PLRX price (monthly, adj. close)

Other funds also holding PLRX

As of 2025 Q4 — sorted by position size

BML Capital Management, LLC 3Y 1.63% Monaco Asset Management SAM 3Y 0.41% Prosight Management, LP 3Y 7Y 0.39% TANG CAPITAL MANAGEMENT LLC 3Y 7Y 0.37% Blue Owl Capital Holdings LP 3Y 0.27% Seven Fleet Capital Management LP 0.26% NANO CAP NEW MILLENNIUM GROWTH FUND L P 0.24% Rangeley Capital, LLC 0.23% Redmile Group, LLC 3Y 7Y 0.15% TORNO CAPITAL, LLC 0.09%
← Back to Stonepine Capital Management, LLC Holdings